TransMedics (TMDX) Return on Capital Employed (2019 - 2026)

TransMedics' Return on Capital Employed history runs 8 years deep, the most recent figure standing at 8.14% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 128.0% year-over-year to 8.14%; the TTM figure through Mar 2026 stood at 8.14% (up 128.0% YoY), while the FY2025 annual figure was 12.82%, up 743.0% from the prior year.
• Return on Capital Employed was 8.14% for Q1 2026 at TransMedics, down from 11.83% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 11.83% in Q4 2025 to a low of 43.07% in Q2 2022.
• Historically, Return on Capital Employed has averaged 4.89% across 5 years, with a median of 2.14% in 2024.
• The sharpest annual moves came in 2022 and 2023: Return on Capital Employed slumped 2208 bps in 2022, then soared 3972 bps in 2023.
• A 5-year view of Return on Capital Employed shows it stood at 12.46% in 2022, then jumped by 64 bps to 4.47% in 2023, then jumped by 214 bps to 5.1% in 2024, then soared by 132 bps to 11.83% in 2025, then slumped by 31 bps to 8.14% in 2026.
• The last three Return on Capital Employed figures came in at 8.14% (Q1 2026), 11.83% (Q4 2025), and 11.44% (Q3 2025), per Business Quant data.